GENOTYPE 2 AND 3 RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY

MLA

Ponziani FR, et al. Genotype 2 and 3 Recurrent Hepatitis C After Liver Transplantation: Excellent Results with Suboptimal Doses of Antiviral Therapy. Jan. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1299..878cc30b454237dd2bc79681434fcec4&authtype=sso&custid=ns315887.

APA

Ponziani FR, Vigano R, Belli L, Pinzello G, Colledan M, De Martin E, Burra P, Boninsegna S, Donato F, Di Paolo D, Angelico M, Rendina M, Pompili M, Gasbarrini A, & Fagiuoli S. (2009). Genotype 2 and 3 Recurrent Hepatitis C After Liver Transplantation: Excellent Results with Suboptimal Doses of Antiviral Therapy.

Chicago

Ponziani FR, Vigano R, Belli L, Pinzello G, Colledan M, De Martin E, Burra P, et al. 2009. “Genotype 2 and 3 Recurrent Hepatitis C After Liver Transplantation: Excellent Results with Suboptimal Doses of Antiviral Therapy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1299..878cc30b454237dd2bc79681434fcec4&authtype=sso&custid=ns315887.